文献速递前列腺癌

前列腺特异性抗原分层预测接近推荐筛查年龄上限男性晚期前列腺癌事件

Prostate-Specific Antigen Stratification for Predicting Advanced Prostate Cancer Events in Men Approaching Age Limits for Recommended Screening.
PubMed 文献 · J Urol · 2024-07-05

研究基于美国退伍军人健康管理局随机样本80706名70至75岁接受PSA检测的男性,评估不同PSA值预测转移性或致死性前列腺癌的能力。PSA的预测区分度随时间下降,曲线下面积5年0.83、10年0.77、14年0.73;PSA阈值1至8 ng/mL时黑人患者阳性预测值显著高于白人。结论认为该年龄段临界升高PSA者风险可量化且相对较低,风险评估须考虑黑人前列腺癌发病率更高。

要点

  • 70至75岁男性PSA预测晚期前列腺癌的区分度随时间下降,曲线下面积5年0.83、10年0.77、14年0.73。
  • PSA阈值1至8 ng/mL时,黑人患者发生晚期前列腺癌的阳性预测值显著高于白人患者。
  • PSA>3 ng/mL时白人5、10、14年事件风险分别为2.4%、2.9%、3.7%,黑人分别为4.3%、6.5%、8.3%。

核心结论

  • 对于70至75岁、PSA临界升高并决定是否停止PSA检测的男性,发生转移性或致死性前列腺癌的风险可量化且相对较低。
  • 该情境下的风险评估必须考虑黑人男性前列腺癌发病率更高。

研究设计与样本

  • 研究采用美国退伍军人健康管理局患者的随机样本,识别出80706名在70至75岁间接受过PSA检测的男性。
  • 主要终点为发生转移性前列腺癌或死于前列腺癌的时间。
  • 采用累积/动态模型处理竞争事件(非前列腺癌原因死亡),并评估PSA的区分能力及3个时间点的阳性预测值和阴性预测值。

主要发现

  • PSA显示出时间依赖的预测区分度,受试者工作特征曲线下面积在5年、10年、14年分别为0.83、0.77、0.73。
  • 按种族分层时,PSA的预测区分度无统计学显著差异。
  • 在PSA阈值1至8 ng/mL之间,黑人患者发生晚期前列腺癌的阳性预测值显著高于白人患者。
  • 以PSA>3 ng/mL为例,白人患者在5年、10年、14年的事件风险分别为2.4%、2.9%、3.7%,黑人患者分别为4.3%、6.5%、8.3%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Our goal was to quantify the ability of various PSA values in predicting the likelihood of developing metastatic or fatal prostate cancer in older men. MATERIALS AND METHODS: We used a random sample of patients in the US Veterans Health Administration to identify 80,706 men who had received PSA testing between ages 70 to 75. Our primary end point was time to development of either metastatic prostate cancer or death from prostate cancer. We used cumulative/dynamic modeling to account for competing events (death from non-prostate cancer causes) in studying both the discriminative ability of PSA as well as for positive predictive value and negative predictive value at 3 time points. RESULTS: PSA demonstrated time-dependent predictive discrimination, with receiver operating characteristic area under the curve at 5, 10, and 14 years decreasing from 0.83 to 0.77 to 0.73, respectively, but without statistically significant difference when stratified by race. At PSA thresholds between 1 and 8 ng/mL, the positive predictive value of developing advanced prostate cancer was significantly greater in Black than White patients. For instance, at a PSA > 3, at 5, 10, and 14 years, White patients had 2.4%, 2.9%, and 3.7% risk of an event, whereas Black patients had 4.3%, 6.5%, and 8.3% risk. CONCLUSIONS: In men aged 70 to 75 deciding whether to cease PSA testing with borderline-elevated PSA values, the risk of developing metastatic or fatal prostate cancer is quantifiable and relatively low. Risk assessment in this setting must account for the higher incidence of prostate cancer in Black men.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Riviere P, Deshler LN, Morgan KM, et al. Prostate-Specific Antigen Stratification for Predicting Advanced Prostate Cancer Events in Men Approaching Age Limits for Recommended Screening. J Urol. 2024. PMID: 38968170. doi:10.1097/JU.0000000000004138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。